0.615
0.16%
0.001
Retractable Technologies Inc (RVP) 最新ニュース
Safety Syringes Market: Safeguarding Healthcare with Advanced Needle Safety Solutions - openPR
Retractable Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Retractable Technologies reports loss of USD 5.1M in Q3 2024 - Medical Buyer
Retractable Technologies: Q3 Earnings Snapshot - New Haven Register
Retractable Technologies Inc (RVP) Quarterly 10-Q Report - Quartzy
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - The Bakersfield Californian
Retractable Technologies Reports Steep Q3 Loss as Margins Collapse, Tariffs Bite | RVP Stock News - StockTitan
Retractable Technologies CEO Thomas Shaw acquires $5,422 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock By Investing.com - Investing.com Australia
RVP stock touches 52-week low at $0.7 amid market challenges - Investing.com Australia
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock - Investing.com India
Disposable Syringes Market Overall Study Report 2024-2031 | B. - openPR
Feds Can Hold Proceeds During Chinese Syringe Duties Fight - Law360
Retractable Technologies CEO Thomas J. Shaw acquires $6,876 in stock - Investing.com
Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock By Investing.com - Investing.com UK
Retractable Technologies stock hits 52-week low at $0.71 By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw buys shares for $429 - Investing.com
Retractable Technologies CEO Thomas Shaw buys shares for $429 By Investing.com - Investing.com Australia
Retractable Technologies stock hits 52-week low at $0.71 - Investing.com India
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock By Investing.com - Investing.com Australia
Retractable Technologies CEO Shaw buys $6,061 in stock By Investing.com - Investing.com South Africa
Retractable Technologies CEO Shaw buys $6,061 in stock - Investing.com
Safety Syringes Market 2024-2031 Global Industry Analysis, - openPR
Smart Syringes Market Projected to Surge to USD 143.93 Million by 2031 - WhaTech
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock - Investing.com India
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock By Investing.com - Investing.com South Africa
Hypodermic Needles Market Generated Opportunities, Future - openPR
Venous Blood Collection Market to Witness Huge Growth by 2032 |Terumo, BD, Bio Rad Laboratories, Nipro - openPR
Retractable sues Becton alleging patent infringement - Reuters
Disposable Syringes Market Forecasting Dynamic Growth: - openPR
Smart Syringes Industry: Insights from Latest Research Report on Business Opportunities by (2024-2034) - IndiaPolitics.com
U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of - Daily Guardian Canada
U.S. Disposable Syringes Market Analysis 2024-2030: Rising - GlobeNewswire
大文字化:
|
ボリューム (24 時間):